Annales Pharmaceutiques Francaises, volume 79, issue 5, pages 500-510
Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study
Sokol M
1
,
Mollaev Murad D
2
,
Zabolotsky A
3
,
Nikolskaya E
,
Zenin V
4
,
Mollaeva M
1
,
Fomicheva M
1
,
Kuznetsov S.
5
,
Popenko V
,
Seregina I
,
Попенко В. И.
6
,
Seregina Irina F
3
,
1
Russian Research Center for Molecular Diagnostics and Therapy, 117638 Moscow, Russian Federation
|
Publication type: Journal Article
Publication date: 2021-09-01
Journal:
Annales Pharmaceutiques Francaises
Quartile SCImago
Q3
Quartile WOS
—
Impact factor: 1.2
ISSN: 00034509
Pharmacology
Pharmaceutical Science
Abstract
The goal of this study was to develop sample preparation method and validate the HPLC method for precise determination of paclitaxel (Ptx) in PLGA submicron particles conjugated with protein vector molecule.Ptx loaded PLGA submicron particles were formulated by a single emulsification method. PLGA submicron particles were conjugated with alpha fetoprotein third domain (rAFP3d) via standard carbodiimide technique. The obtained conjugate was analyzed using 1525 binary pump and 2487 UV-VIS detector system (Waters, USA) and Reprosil ODS C-18 analytical column with the dimensions of 150mm×4.6mm ID×5μm (Dr. Maisch GmbH, Germany). Sample preparation method was developed utilizing guard cartridge with С18 stationary phase (Phenomenex, USA). HPLC method was validated according to the international conference on harmonization guidelines.Efficient sample preparation was achieved using 4% of DMSO pre-dissolution, following by 10min of centrifugation at 4500g. Ptx determination was performed using acetonitrile/0.1% phosphoric acid (50:50 v/v) mobile phase at a flow rate of 1.0mL/min, injection volume of 10μL, and at 227nm. The developed method showed linearity, accuracy and precision in the range from 0.03 to 360μg/mL, with LOD and LOQ values of 0.005 and 0.03μg/mL, respectively. The intra- and inter-day precisions presented RSD values of lower than 2%.The validated method was successfully applied to calculate Ptx encapsulation efficacy and drug loading in the developed formulation.
Citations by journals
1
|
|
Drug development & registration
|
Drug development & registration
1 publication, 50%
|
International Journal of Nanomedicine
|
International Journal of Nanomedicine
1 publication, 50%
|
1
|
Citations by publishers
1
|
|
Center of Pharmaceutical Analytics Ltd
|
Center of Pharmaceutical Analytics Ltd
1 publication, 50%
|
Dove Medical Press
|
Dove Medical Press
1 publication, 50%
|
1
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2021,2022,2023],"ids":[0,0,0],"codes":[0,0,0],"imageUrls":["","",""],"datasets":[{"label":"Citations number","data":[1,0,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6"],"percentage":["50",0,"50"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["Drug development & registration","International Journal of Nanomedicine"],"ids":[26766,10956],"codes":[0,0],"imageUrls":["\/storage\/images\/resized\/ewwj5yBvA6wToa4jkXRrcDjN2omUCp6UYltwKhS8_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp"],"datasets":[{"label":"","data":[1,1],"backgroundColor":["#3B82F6","#3B82F6"],"percentage":[50,50],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Center of Pharmaceutical Analytics Ltd","Dove Medical Press"],"ids":[7156,417],"codes":[0,0],"imageUrls":["\/storage\/images\/resized\/ewwj5yBvA6wToa4jkXRrcDjN2omUCp6UYltwKhS8_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp"],"datasets":[{"label":"","data":[1,1],"backgroundColor":["#3B82F6","#3B82F6"],"percentage":[50,50],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Sokol M. et al. Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study // Annales Pharmaceutiques Francaises. 2021. Vol. 79. No. 5. pp. 500-510.
GOST all authors (up to 50)
Copy
Sokol M., Zenin V., Yabbarov N. G., Mollaev M. D., Zabolotsky A., Mollaeva M., Fomicheva M., Kuznetsov S., Popenko V., Seregina I., Nikolskaya E., Попенко В. И., Seregina I. F., Nikolskaya E. D. Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study // Annales Pharmaceutiques Francaises. 2021. Vol. 79. No. 5. pp. 500-510.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.pharma.2021.02.001
UR - https://doi.org/10.1016%2Fj.pharma.2021.02.001
TI - Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study
T2 - Annales Pharmaceutiques Francaises
AU - Sokol, M
AU - Zenin, V
AU - Yabbarov, Nikita G
AU - Mollaev, Murad D
AU - Zabolotsky, A
AU - Mollaeva, M
AU - Fomicheva, M
AU - Kuznetsov, S.
AU - Popenko, V
AU - Seregina, I
AU - Nikolskaya, E
AU - Попенко, В. И.
AU - Seregina, Irina F
AU - Nikolskaya, Elena D
PY - 2021
DA - 2021/09/01 00:00:00
PB - Elsevier
SP - 500-510
IS - 5
VL - 79
SN - 0003-4509
ER -
Cite this
BibTex
Copy
@article{2021_Sokol
author = {M Sokol and V Zenin and Nikita G Yabbarov and Murad D Mollaev and A Zabolotsky and M Mollaeva and M Fomicheva and S. Kuznetsov and V Popenko and I Seregina and E Nikolskaya and В. И. Попенко and Irina F Seregina and Elena D Nikolskaya},
title = {Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study},
journal = {Annales Pharmaceutiques Francaises},
year = {2021},
volume = {79},
publisher = {Elsevier},
month = {sep},
url = {https://doi.org/10.1016%2Fj.pharma.2021.02.001},
number = {5},
pages = {500--510},
doi = {10.1016/j.pharma.2021.02.001}
}
Cite this
MLA
Copy
Sokol, M., et al. “Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study.” Annales Pharmaceutiques Francaises, vol. 79, no. 5, Sep. 2021, pp. 500-510. https://doi.org/10.1016%2Fj.pharma.2021.02.001.